Globe Life Inc.: Q1 FY2026 earnings call

What management said about Q1 FY2026, from the documents filed with the SEC on 22 April 2026: press release. Guidance figures: 1 raised. The quarter’s numbers.

Key takeaways

Net income and operating income rose: Net income was $3.39 per diluted share against $3.01. Net operating income was $3.43 against $3.07, up 12%. Source
Full-year earnings guidance raised: Full-year 2026 earnings guidance is $15.40 to $15.90 per diluted share, up from $14.95 to $15.65; the midpoint rose $0.35. Source
United American health net sales rose: United American health net sales were about $62 million against $28 million; health underwriting margin was about $5 million against $2 million. Source
Life net sales grew at each division: Total life net sales were $157.4 million, up 6%, with each division's life net sales higher than a year earlier. Source
Shares repurchased for $203 million: 1.4 million shares were repurchased for $203 million, at an average price of $141.24 per share. Source
Book value per share rose 19%: Book value per share was $77.03, up 19% from $64.50. Excluding AOCI it was $98.56, up 12% from $87.92. Source

“Management views the business in this manner because it creates more meaningful and easily identifiable trends, as we exclude fluctuations resulting from changes in interest rates.”
Globe Life Inc., press release

Guidance

Area	Period	Figure	Against last quarter
Earnings per diluted share, full year Source	Year ending December 31, 2026	$15.40 to $15.90	Raised from $14.95 to $15.65

What changed from last quarter

Guidance raised: Full-year 2026 earnings guidance raised from $14.95 to $15.65 to $15.40 to $15.90 per diluted share. Source

Results and earnings

Net income and operating income rose: Net income was $3.39 per diluted share against $3.01. Net operating income was $3.43 against $3.07, up 12%. Source
Full-year earnings guidance raised: Full-year 2026 earnings guidance is $15.40 to $15.90 per diluted share, up from $14.95 to $15.65; the midpoint rose $0.35. Source
Insurance underwriting income rose: Insurance underwriting income was $352.4 million, up 5%. Per share it was $4.42 against $3.98, up 11%. Source
Net investment income rose: Net investment income was $289.8 million against $280.6 million, up 3%. Average invested assets rose about 2%. Source

Segments and distribution channels

United American health net sales rose: United American health net sales were about $62 million against $28 million; health underwriting margin was about $5 million against $2 million. Source
Family Heritage health sales rose: Family Heritage health net sales were $32.7 million, up 22%. Health premium rose 10% and average producing agents rose 10%. Source
Direct to Consumer life margin rose: Direct to Consumer life underwriting margin was $73.6 million, up 15%. Its life net sales were $27.2 million, up 8%. Source
American Income life net sales rose: American Income life net sales were $101.3 million, up 3%. Its life premium was $459.2 million, up 5%. Source

“These cash flows are not impacted by volatile equity markets.”
Globe Life Inc., press release

Products, customers and sales

Life net sales grew at each division: Total life net sales were $157.4 million, up 6%, with each division's life net sales higher than a year earlier. Source
Health share of premium and margin: Health was 21% of insurance underwriting margin and 33% of total premium revenue; life was 79% and 67% respectively. Source
Premium revenue rose 6%: Total premium revenue was $1,270.1 million, up 6%: life premium $853.2 million, up 3%, and health premium $416.9 million, up 13%. Source
Producing agent counts mixed: Quarterly average producing agents: American Income 11,064, down 4%; Liberty National 4,031, up 9%; Family Heritage 1,561, up 10%. Source
Health net sales rose 58%: Total health net sales were $106.2 million against $67.2 million, up 58%. Source

Costs and margins

Administrative expense ratio edged up: Administrative expenses were $94.3 million against $87.5 million a year earlier, or 7.4% of premium against 7.3%. Source
Other life margin fell 31%: Other life underwriting margin was $31.1 million, down 31% from $45.1 million; as a share of its premium it was 62% against 90%. Source
Income tax expense rose 4%: Income tax expense was $67.7 million, up 4%, or $0.85 per share against $0.77. Source

Investments and portfolio

Portfolio yield edged higher: Fixed maturity portfolio yield was 5.32%, against 5.25% a year earlier. Source
Fixed maturities rated 97% investment grade: 97% of fixed maturities were rated investment grade; below-investment-grade amortized cost was $510.6 million of the $19.1 billion total. Source
Net unrealized losses on fixed maturities: Available-for-sale fixed maturities showed net unrealized losses of $1,550,712 thousand at March 31, 2026, recorded in AOCI; fair value was $17.58 billion. Source
Excess investment income rose 2%: Excess investment income was $36.7 million, up 2%. Per diluted share it was $0.46 against $0.42, up 10%, a measure that takes repurchases into account. Source
New fixed maturity purchases rose: Fixed maturity acquisitions were $418.8 million against $244.8 million, at an average annual effective yield of 6.2% against 6.4%, average rating A against A-. Source

Capital and shareholder returns

Shares repurchased for $203 million: 1.4 million shares were repurchased for $203 million, at an average price of $141.24 per share. Source
Book value per share rose 19%: Book value per share was $77.03, up 19% from $64.50. Excluding AOCI it was $98.56, up 12% from $87.92. Source
ROE excluding AOCI at 14.0%: Net operating income as an ROE excluding AOCI was 14.0%, against 14.1% a year earlier. Source
Parent liquidity sufficient for insurers: Parent company liquidity is described as sufficient to meet additional capital needs of the insurance companies. Source
Diluted share count declined: Weighted average diluted shares were 79,741 thousand against 84,480 thousand; interest on debt was $34.0 million, down 3%. Source

Coming up, as management said on 22 April 2026

Supplemental reports before the call: Supplemental financial reports are to be posted on the Investors page immediately after the release and before the call. Source

Figures management reported

Figure	Reported
Book value per share Source	$77.03; $98.56 excluding AOCI
Investment income Source	net investment income $289,824 thousand; excess investment income $36,654 thousand

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.

As filed with the SEC

Open the filing on EDGAR

GLOBE LIFE INC. REPORTS

First Quarter 2026 Results

McKinney, TX, April 22, 2026 - Globe Life Inc. (NYSE: GL) reported today that for the quarter ended March 31, 2026, net income was $3.39 per diluted common share, compared with $3.01 per diluted common share for the year-ago quarter. Net operating income was $3.43 per diluted common share, compared with $3.07 per diluted common share for the year-ago quarter. The Company also increased full-year 2026 earnings guidance to a range of $15.40 to $15.90, an increase of $0.35 at the midpoint.

HIGHLIGHTS:

Net income as an ROE was 17.9% for the three months ended March 31, 2026. Book value per share was $77.03, an increase of 19% over the year-ago quarter.
Net operating income as an ROE excluding accumulated other comprehensive income (AOCI) was 14.0% for the three months ended March 31, 2026. Book value per share excluding AOCI was $98.56, an increase of 12% over the year-ago quarter.
Net income per share increased 13% and net operating income per share increased 12% over the year-ago quarter.
Life net sales grew at each division, resulting in a 6% increase in total life net sales over the year-ago quarter.
At the American Income Life Division, life underwriting margin increased 7%, life premium increased 5%, and life net sales increased 3% over the year-ago quarter.
At the Liberty National Division, life net sales increased 13% and life underwriting margin increased 11% over the year-ago quarter. Additionally, the average producing agent count increased 9% over the year-ago quarter.
At the Family Heritage Division, health net sales increased 22%, health underwriting margin increased 11%, and health premium increased 10% over the year-ago quarter. Additionally, the average producing agent count increased 10% over the year-ago quarter.
At the Direct to Consumer Division, life underwriting margin increased 15% and life net sales increased 8% over the year-ago quarter.
At the United American Division, health net sales increased from $28 million to approximately $62 million and health underwriting margin increased from approximately $2 million to $5 million over the year-ago quarter. Health premium increased 22% over the year-ago quarter.
1.4 million shares of Globe Life Inc. common stock were repurchased during the quarter at a total cost of $203 million.

Note: As used in the earnings release, "Globe Life," the "Company," "we," "our," and "us" refer to Globe Life Inc., a Delaware corporation incorporated in 1979, its subsidiaries and affiliates.

Earnings Release - Q1 2026

RESULTS OF OPERATIONS

Net operating income, a non-GAAPfinancial measure, has been used consistently by Globe Life’s management for many years to evaluate the operating performance of the Company, and is a measure commonly used in the life insurance industry. It differs from net income primarily because it excludes certain non-operating items such as realized investment gains and losses and certain significant and unusual items included in net income. Management believes an analysis of net operating income is important in understanding the profitability and operating trends of the Company’s business. Net income is the most directly comparable GAAP measure.

The following table represents Globe Life's operating summary for the three months ended March 31, 2026 and 2025:

	Per Share
	Three Months Ended March 31,			Three Months Ended March 31,
	2026	2025	% Chg.	2026	2025	% Chg.
Operating Summary
Insurance underwriting income	$4.42	$3.98	11	$352,405	$336,315	5
Excess investment income	0.46	0.42	10	36,654	35,870	2
Interest on debt	(0.43)	(0.41)	5	(34,000)	(34,992)	(3)
Parent company expense	(0.04)	(0.04)		(3,533)	(3,050)
Income tax expense	(0.85)	(0.77)	10	(67,703)	(64,891)	4
Stock compensation benefit (expense), net of tax	(0.13)	(0.12)		(10,303)	(9,915)
Net operating income	3.43	3.07	12	273,520	259,337	5
Reconciling items, net of tax:
Realized gain (loss)	(0.01)	-		(1,167)	67
Non-operating expenses	-	-		(72)	-
Legal proceedings	(0.02)	(0.06)		(1,755)	(4,841)
Net income	$3.39	$3.01		$270,526	$254,563
Weighted average diluted shares outstanding	79,741	84,480

(1)GAAP is defined as accounting principles generally accepted in the United States of America.

(2)Definitions included within this document.

(3)A GAAP-basis condensed consolidated statement of operations is included in the appendix of this report.

Note: Tables in this earnings release may not sum due to rounding.

Earnings Release - Q1 2026

MANAGEMENT VS. GAAP MEASURES

Shareholders' equity, excluding AOCI, and book value per share, excluding AOCI, are non-GAAP measures that are utilized by management to view the business without the effect of changes in AOCI, which are primarily attributable to fluctuation in interest rates. Management views the business in this manner because it creates more meaningful and easily identifiable trends, as we exclude fluctuations resulting from changes in interest rates. Shareholders' equity and book value per share are the most directly comparable GAAP measures.

	Three Months Ended March 31,
	2026		2025
Net income	$270,526		$254,563
Net operating income	273,520		259,337
Net income as an ROE	17.9%		19.0%
Net operating income as an ROE (excluding AOCI)	14.0%		14.1%
	March 31,
		2026		2025
Shareholders' equity	$6,084,596		$5,425,416
Impact of adjustment to exclude AOCI	1,700,791		1,970,873
Shareholders' equity, excluding AOCI	$7,785,387		$7,396,289
Book value per share	$77.03		$64.50
Impact of adjustment to exclude AOCI	21.53		23.42
Book value per share, excluding AOCI	$98.56		$87.92

(1) Calculated using average shareholders' equity for the measurement period.

Earnings Release - Q1 2026

INSURANCE OPERATIONS:

Life insurance accounted for 79% of the Company’s insurance underwriting margin for the quarter and 67% of total premium revenue.

Health insurance accounted for 21% of the Company's insurance underwriting margin for the quarter and 33% of total premium revenue.

Net sales of life insurance increased 6% for the quarter, and net health sales increased 58%.

The following table summarizes Globe Life's premium revenue by product type for the three months ended March 31, 2026 and 2025:

	Quarter Ended
	March 31, 2026	March 31, 2025	% Chg.
Insurance Premium Revenue
Life insurance	$853,205	$829,863	3
Health insurance	416,908	369,791	13
Total	$1,270,113	$1,199,654	6

INSURANCE UNDERWRITING INCOME

Insurance underwriting margin is management’s measure of profitability of the Company's life and health segments’ underwriting performance, and consists of premiums less policy obligations (excluding interest on policy liabilities), commissions and other acquisition expenses. Insurance underwriting income is the sum of the insurance underwriting margins of the life and health segments, plus annuity and other income, less administrative expenses. It excludes the investment segment, interest on debt, Parent Company expense, stock compensation expense and income taxes. Management believes this information helps provide a better understanding of the business and a more meaningful analysis of underwriting results by distribution channel. Insurance underwriting income, a non-GAAP measure, is a component of net operating income, which is reconciled to net income in the Results of Operations section above.

The following table summarizes Globe Life's insurance underwriting income by segment for the three months ended March 31, 2026 and 2025:

	Quarter Ended
	March 31, 2026	% of Premium	March 31, 2025	% of Premium	% Chg.
Insurance Underwriting Income
Insurance underwriting margins:
Life	$349,058	41	$337,264	41	3
Health	94,504	23	84,721	23	12
	443,562		421,985		5
Annuity and other income	3,129		1,879
Administrative expenses	(94,286)		(87,549)
Insurance underwriting income	$352,405		$336,315		5
Per share	$4.42		$3.98		11

The ratio of administrative expenses to premium was 7.4%, compared with 7.3% for the year-ago quarter.

Earnings Release - Q1 2026

LIFE INSURANCE RESULTS BY DISTRIBUTION CHANNEL

Our distribution channels consist of the following exclusive divisions: American Income Life Division (American Income), Liberty National Division (Liberty National), Family Heritage Division (Family Heritage), Direct to Consumer Division (Direct to Consumer); and an independent agency, United American Division (United American).

Total premium, underwriting margins, first-year collected premium and net sales by all distribution channels are shown at https://investors.globelifeinsurance.com at "Financial Reports and Other Financial Information."

	Quarter Ended
	March 31,
	2026		2025
	Amount	% of Premium	Amount	% of Premium	% Chg.
Life Underwriting Margin
American Income	$209,008	46	$196,169	45	7
Direct to Consumer	73,638	30	64,200	26	15
Liberty National	35,292	35	31,772	33	11
Other	31,120	62	45,123	90	(31)
Total	$349,058	41	$337,264	41	3

	Quarter Ended
	March 31,
	2026	2025	% Chg.
Life Premium
American Income	$459,200	$437,866	5
Direct to Consumer	244,223	245,600	(1)
Liberty National	99,885	96,182	4
Other	49,897	50,215	(1)
Total	$853,205	$829,863	3

	Quarter Ended
	March 31,
	2026	2025	% Chg.
Life Net Sales
American Income	$101,337	$98,555	3
Direct to Consumer	27,188	25,175	8
Liberty National	25,358	22,469	13
Other	3,488	2,152	62
Total	$157,371	$148,351	6

(1)Net sales is calculated as annualized premium issued, net of cancellations in the first thirty days after issue, except in the case of Direct to Consumer, where net sales is annualized premium issued at the time the first full premium is paid after any introductory offer period (typically 1 month) has expired. Management considers net sales to be a better indicator of the rate of premium growth than annualized premium issued since annualized premium issued is before cancellations, as cancellations do not contribute to premium income.

Earnings Release - Q1 2026

HEALTH INSURANCE RESULTS BY DISTRIBUTION CHANNEL

	Quarter Ended
	March 31,
	2026		2025
	Amount	% of Premium	Amount	% of Premium	% Chg.
Health Underwriting Margin
United American	$5,281	3	$1,617	1	227
Family Heritage	43,745	36	39,249	35	11
Liberty National	25,670	54	25,982	54	(1)
American Income	18,771	60	19,389	63	(3)
Direct to Consumer	1,037	5	(1,516)	(8)
Total	$94,504	23	$84,721	23	12

	Quarter Ended
	March 31,
	2026	2025	% Chg.
Health Premium
United American	$194,426	$159,848	22
Family Heritage	123,139	112,354	10
Liberty National	47,579	47,922	(1)
American Income	31,119	30,691	1
Direct to Consumer	20,645	18,976	9
Total	$416,908	$369,791	13

	Quarter Ended
	March 31,
	2026	2025	% Chg.
Health Net Sales
United American	$61,534	$27,708	122
Family Heritage	32,713	26,816	22
Liberty National	6,968	7,198	(3)
American Income	4,317	4,870	(11)
Direct to Consumer	618	645	(4)
Total	$106,150	$67,237	58

Earnings Release - Q1 2026

PRODUCING EXCLUSIVE AGENT COUNT RESULTS BY DISTRIBUTION CHANNEL

	Quarterly Average Producing Agent Count
	Quarter Ended			Quarter Ended
	March 31,			December 31,
	2026	2025	% Chg.	2025
American Income	11,064	11,510	(4)	11,699
Liberty National	4,031	3,688	9	3,965
Family Heritage	1,561	1,417	10	1,640

(1) The quarterly average producing agent count is based on the actual count at the beginning and end of each week during the period.

INVESTMENTS

Management uses excess investment income as the measure to evaluate the performance of the investment segment. It is defined as net investment income less the required interest attributable to policy liabilities. We also view excess investment income per diluted common share as an important and useful measure to evaluate performance of the investment segment, since it takes into consideration our stock repurchase program.

The following table summarizes Globe Life's investment income, excess investment income, and excess investment income per diluted common share.

	Quarter Ended
	March 31,
	2026	2025	% Chg.
Excess Investment Income
Net investment income	$289,824	$280,614	3
Interest on policy liabilities	(253,170)	(244,744)	3
Excess investment income	$36,654	$35,870	2
Per share	$0.46	$0.42	10

(1)Interest on policy liabilities, at original discount rates, is a component of total policyholder benefits, a GAAP measure.

Net investment income increased 3% and average invested assets increased approximately 2%. Required interest on policy liabilities increased 3% and average policy liabilities increased 4%.

Earnings Release - Q1 2026

The composition of the investment portfolio at book value at March 31, 2026 is as follows:

	As of
	March 31, 2026
	Amount	% of Total
Investment Portfolio
Fixed maturities at fair value	$17,579,376	86
Mortgage loans	461,025	2
Policy loans	749,108	4
Other long-term investments	1,435,099	7
Short-term investments	183,790	1
Total	$20,408,398

(1) As of March 31, 2026, fixed maturities at amortized cost were $19.1 billion, net of $3.3 million of allowance for credit losses.

(2) Includes $1.07 billion of investments accounted for under the fair value option which have a cost of $1.06 billion as of March 31, 2026.

Fixed maturities at amortized cost, net of allowance for credit losses, by asset class as of March 31, 2026 are as follows:

	As of
	March 31, 2026
	Investment Grade	Below Investment Grade	Total Amortized Cost, net
Fixed Maturity Portfolio by Sector
Corporate bonds	$14,672,909	$472,686	$15,145,595
Municipals	3,401,697	1,960	3,403,657
Government, agencies, and GSEs	465,510	-	465,510
Other asset-backed securities	79,381	35,945	115,326
Total	$18,619,497	$510,591	$19,130,088

(1) Government-Sponsored Enterprises

Below are fixed maturities available for sale by amortized cost, allowance for credit losses, and fair value at March 31, 2026 and the corresponding amounts of net unrealized gains and losses recognized in accumulated other comprehensive income (loss).

As of	Amortized Cost	Allowance for Credit Losses	Net Unrealized Gains (Losses)	Fair Value
March 31, 2026	$19,133,385	$(3,297)	$(1,550,712)	$17,579,376

At amortized cost, net of allowance for credit losses, and at fair value, 97% of fixed maturities were rated “investment grade.” The fixed maturity portfolio earned an annual taxable equivalent effective yield of 5.32% during the first quarter of 2026, compared with 5.25% in the year-ago quarter.

Globe Life is not a party to any credit default swaps and does not participate in securities lending.

Earnings Release - Q1 2026

Comparable information for acquisitions of fixed maturity and other investments is as follows:

	Quarter Ended
	March 31,
	2026	2025
Fixed Maturity Acquisitions
Amount	$418,753	$244,845
Average annual effective yield	6.2%	6.4%
Average rating	A	A-
Average life (in years) to:
Next call	40.3	40.7
Maturity	42.1	43.1

	Quarter Ended
	March 31,
	2026	2025
Other Investment Acquisitions
Limited partnerships	$11,453	$15,831
Mortgage loans	58,519	35,621
Common stock	1,574	502
Company owned life insurance	75,000	-
Total	$146,546	$51,954

SHARE REPURCHASE:

During the quarter, the Company repurchased 1.4 million shares of Globe Life Inc. common stock at a total cost of $203 million and an average share price of $141.24.

LIQUIDITY/CAPITAL:

Globe Life's operations consist primarily of writing basic protection life and supplemental health insurance policies which generate strong and stable cash flows. These cash flows are not impacted by volatile equity markets. Liquidity at the Parent Company is sufficient to meet additional capital needs of the insurance companies.

NON-GAAP MEASURES:

In this news release, Globe Life includes non-GAAP measures to enhance investors' understanding of management's view of the business. The non-GAAP measures are not a substitute for GAAP, but rather a supplement to increase transparency by providing broader perspective. Globe Life's definitions of non-GAAP measures may differ from other companies' definitions. More detailed financial information, including various GAAP and non-GAAP measurements, is located at https://investors.globelifeinsurance.com on the Investors page under “Financial Reports and Other Financial Information."

CAUTION REGARDING FORWARD-LOOKING STATEMENTS:

This press release may contain forward-looking statements within the meaning of the federal securities laws. These prospective statements reflect management’s current expectations, but are not guarantees of future performance. Whether or not actual results differ materially from forward-looking statements may depend on numerous foreseeable and unforeseeable events or developments, which may be national in scope, related to the insurance industry generally, or applicable to the Company specifically. Such events or developments could include, but are not necessarily limited to:

1) Economic and other conditions, including the impact of inflation, immigration, geopolitical events, escalating tariff and non-tariff trade measures imposed by the U.S. and other countries, and other governmental actions on the U.S. economy and/or U.S. consumer confidence, leading to unexpected changes in lapse rates and/or sales of our policies, as well as levels of mortality, morbidity, and utilization of health care services that differ from Globe Life's assumptions;

2) Regulatory developments, including changes in accounting standards or governmental regulations (particularly those impacting taxes and changes to the Federal Medicare program that would affect Medicare Supplement);

3) Market trends in the senior-aged health care industry that provide alternatives to traditional Medicare (such as Health Maintenance Organizations and other managed care or private plans) and that could affect the sales of traditional Medicare Supplement insurance;

4) Interest rate changes that affect product sales, financing costs, and/or investment yields;

5) General economic, industry sector or individual debt issuers’ financial conditions (including developments and volatility arising from geopolitical events, particularly in certain industries that may compromise part of our investment portfolio) that may affect the current market value of securities we own, or that may impair an issuer’s ability to make principal and/or interest payments due on those securities;

6) Changes in the competitiveness of the Company's products and pricing;

7) Litigation results;

8) Levels of administrative and operational efficiencies that differ from our assumptions (including any reduction in efficiencies resulting from increased costs arising from the impact of higher than anticipated inflation);

9) The ability to obtain timely and appropriate premium rate increases for health insurance policies from our regulators;

10) The ability of our subsidiaries to pay dividends to the Parent Company and to receive required regulatory approvals on such amounts;

11) The customer response to new products and marketing initiatives;

12) Reported amounts in the consolidated financial statements which are based on management estimates and judgments which may differ from the actual amounts ultimately realized;

13) Compromise by a malicious actor or other event that causes a loss of secure data from, or inaccessibility to, our computer and other information technology systems;

14) The Company's ability to attract and retain agents;

15) The severity, magnitude, and impact of natural or man-made catastrophic events, including but not limited to pandemics, tornadoes, hurricanes, earthquakes, war and terrorism, on our operations and personnel, commercial activity and demand for our products; and

16) Globe Life’s ability to access the commercial paper and debt markets, particularly if such markets become unpredictable or unstable for a certain period.

Readers are also directed to consider other risks and uncertainties described in other documents on file with the Securities and Exchange Commission, including those described in the "Risk Factors" section of our most recent Annual Report on Form 10-K. Globe Life specifically disclaims any obligation to update or revise any forward-looking statement because of new information, future developments or otherwise.

EARNINGS RELEASE CONFERENCE CALL WEBCAST:

Globe Life will provide a live audio webcast of its first quarter 2026 earnings release conference call with financial analysts at 11:00 am (Eastern) tomorrow, April 23, 2026. Access to the live webcast and replay will be available at https://investors.globelifeinsurance.com on the Calls and Meetings page, at the Conference Calls on the Web icon. Immediately following this press release, supplemental financial reports will be available before the conference call on the Investors page menu of the Globe Life website at “Financial Reports.”

Earnings Release - Q1 2026

APPENDIX

GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

	Three Months Ended March 31,
	2026	2025
Revenue:
Life premium	$853,205	$829,863
Health premium	416,908	369,791
Total premium	1,270,113	1,199,654
Net investment income	289,824	280,614
Realized gains (losses)	(1,478)	85
Other income	1,160	69
Total revenue	1,559,619	1,480,422
Benefits and expenses:
Life policyholder benefits	518,850	509,756
Health policyholder benefits	263,734	233,929
Other policyholder benefits	7,000	7,080
Total policyholder benefits	789,584	750,765
Amortization of deferred acquisition costs	118,282	105,515
Commissions, premium taxes, and non-deferred acquisition costs	169,886	164,323
Other operating expense	113,735	108,746
Interest expense	34,000	34,992
Total benefits and expenses	1,225,487	1,164,341
Income before income taxes	334,132	316,081
Income tax benefit (expense)	(63,606)	(61,518)
Net income	$270,526	$254,563
Basic net income per common share	$3.45	$3.05
Diluted net income per common share	$3.39	$3.01

(1) Net of total remeasurement gain of $18.9 million for the three months ended March 31, 2026, and a total remeasurement gain of $8.5 million for the same period in 2025.

(2)Net of a total remeasurement gain of $6.0 million for the three months ended March 31, 2026, and a total remeasurement gain of $0.4 million for the same period in 2025.

Contacts
For additional information contact:
Mike Majors, Executive Vice President - Chief Strategy Officer Globe Life Inc.7677 Henneman WayP.O. Box 8080McKinney, Texas 75070-8080Phone: 972-569-3627 or email: investors@globe.lifeWebsite: https://investors.globelifeinsurance.com